Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Breaking & Recent News Benitec Biopharma Ltd ADR (Sponsored) (New) BTEBY

Recent & Breaking News (GREY:BTEBY)

Benitec Biopharma advances OPMD orphan disease program

PR Newswire August 8, 2017

Technical Reports on Biotech Equities -- BioDelivery Sciences, BioLine Rx, Benitec Biopharma, and Soligenix

PR Newswire August 1, 2017

Biotech Stock Performance Review -- Cellect Biotechnology, BioDelivery Sciences, BioLine Rx, and Benitec Biopharma

PR Newswire June 6, 2017

How These Biotech Stocks are Faring? -- Cymabay Therapeutics, Benitec Biopharma, Sage Therapeutics, and Catalyst Biosciences

PR Newswire April 26, 2017

25 Stocks Moving In Wednesday's Pre-Market Session

Benzinga.com  April 5, 2017

Mid-Day Market Update: Conn's Surges On Earnings Beat; Seadrill Shares Slide

Benzinga.com  April 4, 2017

Mid-Morning Market Update: Markets Edge Lower; Acuity Brands Misses Q2 Estimates

Benzinga.com  April 4, 2017

Key pre-clinical data on oculopharyngeal muscular dystrophy (OPMD) published in Nature Communications

PR Newswire April 4, 2017

Biotech Stocks Under Scanner -- BioDelivery Sciences, Sage Therapeutics, Benitec Biopharma, and OncoGenex Pharma

PR Newswire March 24, 2017

Benitec Biopharma completes second tranche placement to Nant Capital to raise A$5.45 million

PR Newswire March 13, 2017

Benitec Biopharma to present expanded data set from pivotal data in hepatitis B virus (HBV) in vivo model at International Liver Meeting in Shanghai, China

PR Newswire February 16, 2017

12 Biggest Mid-Day Gainers For Tuesday

Benzinga.com  February 7, 2017

18 Biggest Mid-Day Losers For Friday

Benzinga.com  February 3, 2017

Mid-Afternoon Market Update: Weatherford Rises Following Q4 Results; Ralph Lauren Shares Plunge

Benzinga.com  February 2, 2017

Mid-Day Market Update: Shutterfly Drops On Downbeat Earnings; Mead Johnson Shares Spike Higher

Benzinga.com  February 2, 2017

Benitec Biopharma makes significant progress in ocular program

PR Newswire February 2, 2017

Benitec initiates development work on head and neck cancer programs after executing Collaboration Agreement with Nant Capital

PR Newswire January 30, 2017

Mid-Afternoon Market Update: Crude Oil Up 1.2%; Progress Software Shares Plunge

Benzinga.com  January 17, 2017

Mid-Morning Market Update: Markets Open Lower; Morgan Stanley Tops Q4 Estimates

Benzinga.com  January 17, 2017

Benitec Receives Orphan Drug Designation in the European Union for BB-301, a ddRNAi Therapeutic in Development for the Treatment of Oculopharyngeal Muscular Dystrophy

PR Newswire January 17, 2017